IMARA Inc. logo

IMRA

NASDAQ

IMARA Inc.

SectorHealth CareIndustryBiotechnology: Biological Products (No Diagnostic Substances)IPO2020
$15.66+0.70 (+4.68%)
Website
News25/Ratings3

IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. It develops IMR-687, an oral, once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Price$15.66-1.51 (-8.79%)
2026-01-202026-04-23
News · 26 weeks60%
2025-10-26: 02025-11-02: 02025-11-09: 02025-11-16: 02025-11-23: 12025-11-30: 02025-12-07: 02025-12-14: 02025-12-21: 12025-12-28: 02026-01-04: 02026-01-11: 02026-01-18: 12026-01-25: 02026-02-01: 02026-02-08: 02026-02-15: 02026-02-22: 12026-03-01: 02026-03-08: 02026-03-15: 02026-03-22: 12026-03-29: 02026-04-05: 02026-04-12: 02026-04-19: 1
2025-10-262026-04-19
Mix390d
  • Dividends3(100%)

Latest news

25 items